However, in Glioma (Figure 2D, p < 0.001), KIPAN (Figure 2E, p < 0.001), NB (Figure 2F, p < 0.001), KICH (Figure 2G, p < 0.001), LGG (Figure 2H, p < 0.05 (p = 0.02) and PAAD (Figure 2P, p <= 0.01) patients, the expression of CHD5 was positively correlated with the survival time. This evidence concerns the gene CHD5 and central nervous system cancer.